Notice - Prescription Drug List (PDL): Hydroquinone
The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the Prescription Drug List (PDL) for human use when sold in concentrations greater than 2% in topical products.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice - Prescription Drug List (PDL): HydroquinoneHTMLEnglish publication HTML
-
Notice - Prescription Drug List (PDL): HydroquinoneHTMLFrench publication HTML
Similar records